Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

YCBD stock hub

cbdMD, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

YCBDis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

8.8M

NYSEAMERICAN

Market data

Live price

Current market quote for this ticker.

Current price

YCBD

In the news

Latest news · YCBD

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-43.4

P25 -105.6P50 -46.5P75 -3.1

ROIC-22.7

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All YCBD market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

205

Groups with data

Currency

USD

Showing 205 of 205 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001644903
Company name	cbdMD, Inc.
Country	United States
Country code	US
Cusip	12482W101
Employees	42
Employees Change	-10%
Employees Change Percent	-19.23
Enterprise value	$6M
Exchange	NYSEAMERICAN
Financial currency	USD
First seen	2026-05-09
Industry	Drug Manufacturers - Specialty & Generic
Isin	US12482W4087
Last refreshed	2026-05-10
Market cap	$8.8M
Market cap category	Nano-Cap
Price	$0.84
Price currency	USD
Rev Per Employee	454,616.57x
Sector	Healthcare
Sic	2844
Symbol	YCBD
Website	https://www.cbdmd.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-42.13%
EV Sales Forward	0.36x
EV/Sales	0.32x
FCF yield	-24.18%
P/B ratio	0.94x
P/S ratio	0.46x
PS Forward	0.53x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-12.37%
EBITDA Margin	-6.75%
Gross margin	60.59%
Gross Profit	$11.6M
Gross Profit Growth	-2.28%
Gross Profit Growth Q	-11.74%
Gross Profit Growth3 Y	-17.91%
Gross Profit Growth5 Y	-16.69%
Net Income	$-3.7M
Net Income Growth Quarters	2%
Net Income Growth Years	3%
Pretax Margin	-12.25%
Profit Margin	-12.25%
Profit Per Employee	$-88,443
ROA	-12.66
Roa5y	-14.43
ROCE	-26.23
ROE	-43.36
Roe5y	-70.99
ROIC	-22.7

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-7.7%
Cagr3y	-62.55%
Cagr5y	-76.96%
EPS Growth Quarters	1
EPS Growth Years	3
Revenue Growth	-0.66x
Revenue Growth Q	-1.89x
Revenue Growth Years	0x
Revenue Growth3 Y	-15.96x
Revenue Growth5 Y	-15.4x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.64
Assets	$11.8M
Cash	$3.4M
Current Assets	$8.2M
Current Liabilities	$2.8M
Debt	$593,026
Debt EBITDA	$1.84
Debt Equity	$0.07
Equity	$9M
Liabilities	$2.8M
Long Term Assets	$3.6M
Long Term Liabilities	$0
Net Cash	$2.8M
Net Cash By Market Cap	$31.7
Net Cash Growth	710.48%
Net Debt Equity	$-0.31
Tangible Book Value	$7.1M
Tangible Book Value Per Share	$0.7
WACC	15.15

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.94
Inventory Turnover	2.68
Net Working Capital	$2.6M
Quick ratio	1.62
Working Capital	$5.4M
Working Capital Turnover	$14.79

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-941.35%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-7.69%
200-day SMA	0.88
3Y total return	-94.75%
50-day SMA	0.79
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.94%
All Time High	2,606.4
All Time High Change	-99.97%
All Time High Date	2019-05-07
All Time Low	0.47
All Time Low Change	78.69%
All Time Low Date	2025-11-21
ATR	0.11
Beta	2.17
Beta1y	2.53
Beta2y	0.79
Ch YTD	-37.78
High	0.86
High52	2.56
High52 Date	2025-12-18
High52ch	-67.19%
Low	0.8
Low52	0.47
Low52 Date	2025-11-21
Low52ch	78.69%
Ma50ch	6.97%
Premarket Change Percent	-4.6
Premarket Price	$0.83
Premarket Volume	30,422
Price vs 200-day SMA	-4.74%
RSI	49.81
RSI Monthly	32.16
RSI Weekly	47.6
Sharpe ratio	0.64x
Sortino ratio	1.73
Total Return	-941.35%
Tr YTD	-37.78
Tr1m	17.48%
Tr1w	-3.45%
Tr3m	-8.98%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	1
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.05
Earnings Revenue Estimate	5,292,000x
Earnings Revenue Estimate Growth	10.25x
Operating Income	$-2.4M
Operating margin	-12.37
Price target	$2
Price Target Change	$138

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	10,197,482%
Float Percent	97.16%
Shares Insiders	2.84%
Shares Institutions	15.64%
Shares Out	10,495,561
Shares Qo Q	0.47%
Shares Yo Y	941.35%
Short Float	3.16%
Short Ratio	0.79
Short Shares	3.07

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-2.2M
Average Volume	3,500,886.35x
Bv Per Share	0.89
CAPEX	$-184,587
Ch1m	17.48
Ch1w	-3.45
Ch1y	-7.69
Ch3m	-8.98
Ch3y	-94.75
Ch5y	-99.94
Ch6m	4.61
Change	-3.45%
Change From Open	-2.34
Close	0.87
Days Gap	-1.14
Depreciation Amortization	1,073,576
Dollar Volume	163,408.6
Earnings Date	2026-05-15
Earnings Time	amc
EBIT	$-2.4M
EBITDA	$-1.3M
EPS	$-0.61
F Score	3
FCF	$-2.1M
FCF EV Yield	-35.4x
FCF Per Share	$-0.2
Financing CF	3,549,193
Fiscal Year End	September
Founded	2,015
Investing CF	-184,587
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-02-17
Last Report Date	2025-12-31
Last Split Date	2025-05-07
Last Split Type	Reverse
Last10k Filing Date	2025-12-19
Ma150	0.91
Ma150ch	-7.59%
Ma20	0.86
Ma20ch	-2.36%
Net CF	1,417,716
Next Earnings Date	2026-05-22
Open	0.86
Optionable	No
Position In Range	66.5
Ppne	920,764
Pre Close	0.87
Price Date	2026-05-08
Ptbv Ratio	1.25
Relative Volume	0.06x
Revenue	19,093,896x
SBC By Revenue	0.1x
Share Based Comp	19,026
Tr6m	4.61%
Us State	North Carolina
Volume	194,534
Z Score	-18.51

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does YCBD pay a dividend?

Capital-return profile for this ticker.

Performance

YCBD stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns YCBD?

Insider, institutional, and short-interest positioning.

Institutional ownership

+15.6%

Float: +97.2% of shares outstanding

Insider ownership

+2.8%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

YCBD momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

49.8

Neutral momentum band

Price vs 200-day MA

-4.7%

50/200-day relationship not available

Beta (5Y)

2.17

More volatile than the market

Sharpe ratio

0.64

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About YCBD

Hub-level FAQ points readers to the deeper analysis pages.

What is the current YCBD stock rating?

cbdMD, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full YCBD analysis?

The full report lives at /stocks/YCBD/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for YCBD?

The latest report frames YCBD around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the YCBD page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.